STOCK TITAN

MARPAI ANNOUNCES PRICING OF $700,000 PRIVATE PLACEMENT

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Very Negative)
Tags
private placement

Marpai (OTCQX: MRAI), a technology platform company operating as a national Third-Party Administrator (TPA), has announced the pricing of a $700,000 private placement. The offering consists of 621,194 shares of Class A common stock at $1.13 per share, for total gross proceeds of $701,950. The investors include an institutional fund and company officers and directors. The closing is expected by December 6, 2024.

The company plans to use the net proceeds for general working capital. The securities are exempt from registration requirements under Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D.

Marpai (OTCQX: MRAI), un'azienda piattaforma tecnologica che opera come un Amministratore Terzo Nazionale (TPA), ha annunciato il prezzo di un collocamento privato di $700,000. L'offerta consiste in 621.194 azioni della Classe A a $1,13 per azione, per un totale di proventi lordi di $701.950. Gli investitori includono un fondo istituzionale e funzionari e direttori della società. La chiusura è prevista entro il 6 dicembre 2024.

La società prevede di utilizzare i proventi netti per il capitale di esercizio generale. I titoli sono esenti dai requisiti di registrazione ai sensi della Sezione 4(a)(2) del Securities Act e della Regola 506(b) del Regolamento D.

Marpai (OTCQX: MRAI), una empresa de plataforma tecnológica que opera como Administrador Tercero Nacional (TPA), ha anunciado el precio de una colocación privada de $700,000. La oferta consiste en 621,194 acciones de la Clase A a $1.13 por acción, para unos ingresos brutos totales de $701,950. Los inversores incluyen un fondo institucional y funcionarios y directores de la empresa. Se espera que el cierre se realice para el 6 de diciembre de 2024.

La empresa planea utilizar los ingresos netos para capital de trabajo general. Los valores están exentos de los requisitos de registro bajo la Sección 4(a)(2) de la Ley de Valores y la Regla 506(b) del Reglamento D.

Marpai (OTCQX: MRAI)는 국가 제3자 관리자로 운영되는 기술 플랫폼 회사로, $700,000의 사모 투자 가격을 발표했습니다. 이번 제안은 주당 $1.13에 판매되는 621,194주의 A급 보통주로 구성되어 있으며, 총 총수익은 $701,950입니다. 투자자에는 기관 펀드와 회사의 임원 및 이사가 포함됩니다. 거래 마감은 2024년 12월 6일로 예상됩니다.

회사는 순수익을 일반 운영 자본으로 사용할 계획입니다. 이 증권은 증권법 제4(a)(2)조 및 규정 D의 506(b) 조항에 따라 등록 요건이 면제됩니다.

Marpai (OTCQX: MRAI), une entreprise de plateforme technologique agissant en tant qu'Administrateur Tiers National (TPA), a annoncé le prix d'un placement privé de 700 000 $. L'offre se compose de 621 194 actions ordinaires de classe A au prix de 1,13 $ par action, pour un produit brut total de 701 950 $. Les investisseurs incluent un fonds institutionnel ainsi que des dirigeants et administrateurs de l'entreprise. La clôture est attendue d'ici le 6 décembre 2024.

L'entreprise prévoit d'utiliser le produit net pour ses besoins en fonds de roulement général. Les titres sont exonérés des exigences d'enregistrement en vertu de la Section 4(a)(2) de la loi sur les valeurs mobilières et de la règle 506(b) du règlement D.

Marpai (OTCQX: MRAI), ein Technologieplattformunternehmen, das als nationaler Dritter-Verwalter (TPA) tätig ist, hat die Preisgestaltung eines Privatplatzierung von $700,000 bekannt gegeben. Das Angebot besteht aus 621.194 Aktien der Klasse A zum Preis von $1,13 pro Aktie, was zu einem gesamten Bruttoeinnahmen von $701.950 führt. Zu den Investoren gehören ein institutioneller Fonds sowie Unternehmensführungsmitglieder und Direktoren. Der Abschluss wird bis zum 6. Dezember 2024 erwartet.

Das Unternehmen plant, die Nettoerlöse für das allgemeine Betriebskapital zu verwenden. Die Wertpapiere sind gemäß Abschnitt 4(a)(2) des Securities Act und Regel 506(b) der Regulation D von den Registrierungsanforderungen befreit.

Positive
  • Secured additional working capital through private placement raising $701,950
Negative
  • Potential dilution of existing shareholders through issuance of 621,194 new shares
  • Small financing amount may indicate investor interest or funding options

TAMPA, Fla., Dec. 5, 2024 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a technology platform company, which operates as a national Third-Party Administrator (TPA) through its subsidiaries and is transforming the $22 billion TPA market by offering affordable, intelligent, healthcare solutions to self-funded employer health plans, today announced the pricing of a private placement offering consisting of the issuance and sale of 621,194 shares of its Class A common stock (the "Common Stock"), par value $0.0001 per share, at a purchase price of $1.13 per Common Stock, for aggregate gross proceeds of $701,950. The investors in the offering consisted of an institutional fund and certain officers and directors of the Company. The closing of the offering is expected to occur on or before December 6, 2024.The company intends to use the net proceeds from the offering for general working capital.

The securities issued in the offering are exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act") pursuant to Section 4(a)(2) of the Securities Act and/or Rule 506(b) of Regulation D promulgated thereunder. The securities have not been registered under the Securities Act and may not be sold in the United States absent registration or an exemption from registration.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Marpai, Inc.

Marpai, Inc. (OTCQX: MRAI) is a technology platform company which operates subsidiaries that provide TPA and value-oriented health plan services to employers that directly pay for employee health benefits. Primarily competing in the $22 billion TPA sector serving self-funded employer health plans representing over $1 trillion in annual claims. Through its Marpai Saves initiative, the Company works to deliver the healthiest member population for the health plan budget. Operating nationwide, Marpai offers access to leading provider networks including Aetna and Cigna and all TPA services. For more information, visit www.marpaihealth.com, the content of which is not incorporated by reference into this press release. Investors are invited to visit https://www.ir.marpaihealth.com

Forward-Looking Statement Disclaimer

This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties. Forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "guidance," "may," "can," "could", "will", "potential", "should," "goal" and variations of these words or similar expressions. For example, the Company is using forward looking statements when it discusses the expected closing date and the intended use of proceeds. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect Marpai's current expectations and speak only as of the date of this release. Actual results may differ materially from Marpai's current expectations depending upon a number of factors. These factors include, among others, adverse changes in general economic and market conditions, competitive factors including but not limited to pricing pressures and new product introductions, uncertainty of customer acceptance of new product offerings and market changes, risks associated with managing the growth of the business. Except as required by law, Marpai does not undertake any responsibility to revise or update any forward-looking statements whether as a result of new information, future events or otherwise.

More detailed information about Marpai and the risk factors that may affect the realization of forward-looking statements is set forth in Marpai's filings with the Securities and Exchange Commission. Investors and security holders are urged to read these documents free of charge on the SEC's web site at http://www.sec.gov.

(PRNewsfoto/Marpai)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/marpai-announces-pricing-of-700-000-private-placement-302324176.html

SOURCE Marpai

FAQ

What is the price per share for Marpai's (MRAI) December 2024 private placement?

Marpai's private placement was priced at $1.13 per share of Class A common stock.

How many shares is Marpai (MRAI) issuing in its December 2024 private placement?

Marpai is issuing 621,194 shares of Class A common stock in the private placement.

What is the total value of Marpai's (MRAI) December 2024 private placement?

The private placement has aggregate gross proceeds of $701,950.

How will Marpai (MRAI) use the proceeds from its December 2024 private placement?

Marpai intends to use the net proceeds from the offering for general working capital.

MARPAI INC A

OTC:MRAI

MRAI Rankings

MRAI Latest News

MRAI Stock Data

6.70M
4.05M
63.71%
13.56%
0.16%
Healthcare Plans
Services-misc Health & Allied Services, Nec
Link
United States of America
TAMPA